Published in Women's Health Weekly, December 31st, 2009
"Correlation of immunoreactivity with clinicopathological variables was evaluated and survival curves were compared between L1-positive and negative cases. L1 was detected in 15 specimens (21%), more often among the intestinal-type cancer. No correlation was observed between L1 expression and presence...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly